The NCEP ATP III was developed to incorporate new evidence and evidence-based strategies to reduce CHD events. Patrick E. McBride, MD, MPH, Director, Preventive Cardiology, Medical Director ...

Rationale for Risk Assessment: Practical Use of the ATP III CHD Risk Assessment The guiding principle of ATP III is that the intensity of cholesterol treatment should be adjusted to the individual ...